Indumati S, Apurva B, Gaurav G, Nehakumari S, Nishant V
95% CI, 0.52 to 0.42), body weight (3.26 percentage points
At the same time, pharmaceutical companies have faced increasing public and regulatory pressure to lower self-pay (cash) prices for these medications though pricing and discount programs vary by drug and pharmacy
We are currently looking for models for this treatment at reduced cost
For research subjects this means stronger appetite control with fewer GI side-effects per kilo lost, plus emerging data on cardiometabolic, liver and sleep-apnoea endpoints
Available for $99 as an add-on after your first month of treatment